Titan Biotech

Titan Biotech EBIT per Share

The EBIT per Share of Titan Biotech (524717.BO) as of Oct 10, 2026 is 9.28 INR. In the previous year, EBIT per Share was 6.09 INR — a change of 52.37% (higher).

EBIT per Share

9.28INR

YoY

52.37%

Last updated:

EBIT per Share of Titan Biotech is 2026 9.28 INR. EBIT per Share of Titan Biotech was 2025 6.09 INR. It decreases by 52.37% higher compared to the previous year.

The Titan Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
1.75 INR
Jan 1, 2020
2.98 INR
Jan 1, 2021
10.55 INR
Jan 1, 2022
7.32 INR
Jan 1, 2023
6.99 INR
Jan 1, 2024
7.91 INR
Jan 1, 2025
6.09 INR
Jan 1, 2026
9.28 INR
The Titan Biotech EBIT per Share history
YEAREBIT per ShareYoY
9.28INR+52.37%
6.09INR-23.03%
7.91INR+13.29%
6.99INR-4.59%
7.32INR-30.60%
10.55INR+254.47%
2.98INR+70.49%
1.75INR+19.36%
1.46INR+32.84%
1.10INR-72.39%
3.99INR+432.12%
0.75INR+30.70%
0.57INR-10.72%
0.64INR+24.18%
0.52INR—
Access this data via the Eulerpool API
Get Free API Key

Titan Biotech Stock analysis

What does Titan Biotech do? Titan Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Titan Biotech stock

EBIT per Share of Titan Biotech is 9.28 INR in 2026.

EBIT per Share of Titan Biotech changed from 6.09 INR to 9.28 INR, representing a 52.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Titan Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Titan Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Titan Biotech